Search

Displaying results 401 - 410 of 10000 in total
  1. Drug

    Risedronic acid

    go.drugbank.com/drugs/DB00884
    ApprovedInvestigational

    Risedronic acid is a third generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label][A959,A203111]. … It functions by preventing resorption of bone[FDA Label][A959].

    Mixtures: RISEPLUS TEDAVI PAKETİ, 4+24 ADET, RISEFIX COMBI TEDAVI PAKETI, 4+24 ADETCategories: Drugs for Treatment of Bone Diseases
  2. Drug

    Beroctocog alfa

    go.drugbank.com/drugs/DB14473
    ApprovedInvestigational

    Products: FACTOR VIII DE COAGULACION HUMANO 500 UI, DRIED FACTOR VIII FRACTION 500 UI + FACTOR DE VON WILLEBRAND 800 UI
  3. Drug

    Tofacitinib

    go.drugbank.com/drugs/DB08895
    ApprovedInvestigational

    Tofacitinib is an inhibitor of Janus kinases, a group of intracellular enzymes involved in signalling pathways that affect hematopoiesis and immune cell function. … Known adverse effects include nausea and headache as well as more serious immunologic and hematological adverse effects. Tofacitinib is marketed under the brand name Xeljanz by Pfizer.

    Products: XELJANZ® XR 11 MG TABLETAS DE LIBERACIÓN MODIFICADA, JANTY 5 MG FİLM KAPLI TABLET, 56 ADET
  4. Drug

    Carya illinoinensis pollen

    go.drugbank.com/drugs/DB10380
    Approved

    Carya illinoinensis pollen allergenic extract is used in allergenic testing.

    Mixtures: Treatment Set TS331413, Treatment Set TS333635Products: Center-AL - Carya Illinoinensis Pollen
  5. Drug

    Mebeverine

    go.drugbank.com/drugs/DB12554
    ApprovedInvestigationalWithdrawn

    Mebeverine has been investigated for the treatment of Irritable Bowel Syndrome and Post-cholecystectomy Gastrointestinal Spasms.

    Products: DUSPATALIN CÁPSULA DE LIBERACIÓN PROLONGADA 200 MG., DUSPATALIN® CÁPSULA DE LIBERACIÓN PROLONGADA 200 MG
  6. Drug

    Lisinopril

    go.drugbank.com/drugs/DB00722
    ApprovedInvestigational

    Lisinopril is an angiotensin converting enzyme inhibitor (ACEI) used to treat hypertension, heart failure, and myocardial infarction. … [A184853] It functions by inhibition of angiotensin converting enzyme as well as the renin angiotensin aldosterone system.

    Mixtures: LISIPLUS AL 10MG/12.5MG, LISIPLUS AL 20MG/12.5MGCategories: Compounds used in a research, industrial, or household setting
  7. Drug

    Olea europaea pollen

    go.drugbank.com/drugs/DB10378
    Approved

    Olea europaea pollen is the pollen of the Olea europaea plant. Olea europaea pollen is mainly used in allergenic testing.

    Products: Center-AL - Olea Europaea Pollen
  8. Drug

    Gentamicin

    go.drugbank.com/drugs/DB00798
    ApprovedInvestigationalVet approved

    [A234364] This synergistic activity is not only important for the treatment of complex infections, but can also contribute to dose optimization and reduced adverse effects. … [A233325,A234359,A234364] There is the added benefit of synergy when gentamicin is co-administered with other antibacterials such as beta-lactams.

    Mixtures: GENTA-DEX EYE DROPS, PHI KANG YANGCategories: OCT2 Substrates with a Narrow Therapeutic Index, Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index
  9. Drug

    Acetylcysteine

    go.drugbank.com/drugs/DB06151
    ApprovedInvestigational

    Acetylcysteine is an antioxidant and glutathione inducer indicated for mucolytic therapy and the treatment of [acetaminophen] overdose. … [L31378,L31383,L31388,L31478] Acetylcysteine has also been studied for a wide variety of off-label indications with mixed results.

    Synonyms: N-ACMixtures: N-ACETILCISTEÍNA MAS GUAYACOLATO DE GLICERILO, ACETILCISTEINA GUAYACOLATO DE GLICERILO JARABE
  10. Drug

    Moxonidine

    go.drugbank.com/drugs/DB09242
    ApprovedInvestigationalWithdrawn

    Moxonidine is a new-generation centrally acting antihypertensive drug approved for the treatment of mild to moderate essential hypertension. … As well, moxonidine has been shown to present blood pressure-independent beneficial effects on insulin resistance syndrome.

    Products: MOXONIDIN AL 0.2MG FILMTAB, MOXONIDIN AL 0.3MG FILMTAB